Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
Cancer Vaccines01:30

Cancer Vaccines

400
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
400
Cancer02:18

Cancer

48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same authorSame journal

Genomic Medicine Sweden: Advancing precision medicine at the national level.

Journal of internal medicine·2026
Same author

Comprehensive comparison of homologous recombination deficiency predictors in early-stage triple-negative breast cancer.

Breast cancer research : BCR·2026
Same author

Towards an ecosystem of clinical decision support tools for precision cancer medicine.

NPJ precision oncology·2026
Same author

ATM Deficiency Induces TGFβ-Mediated Stromal Programming in Pancreatic Cancer.

Cancer research·2026
Same author

Neoadjuvant Atezolizumab and Chemotherapy for Non-Squamous Non-Small Cell Lung Cancer: Efficacy and Safety Results of an Open-Label, Single-Arm, Phase II Trial.

International journal of cancer·2026
Same author

FOCU.SE trial: a nationwide Swedish drug repurposing protocol and research framework.

Acta oncologica (Stockholm, Sweden)·2026

相关实验视频

Updated: Jul 17, 2025

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions
06:18

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions

Published on: April 5, 2024

1.1K

精确癌症医学:概念,现行实践和未来发展

Anders Edsjö1,2,3, Louise Holmquist1,3, Birgit Geoerger4,5

  • 1Department of Clinical Genetics, Pathology and Molecular Diagnostics, Office for Medical Services, Region Skåne, Lund, Sweden.

Journal of internal medicine
|August 29, 2023
PubMed
概括

精确癌症医学的进步依赖于可扩展的分子诊断和适应性测试,以实现个性化瘤学. 未来的进展取决于智能临床试验和协作网络,以改善患者的治疗结果.

关键词:
临床试验是指临床试验中的临床试验.分子诊断 分子诊断 分子诊断个性化瘤学个性化瘤学精确的癌症医学 精确的癌症医学精准医学网络 精准医学网络

更多相关视频

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.0K

相关实验视频

Last Updated: Jul 17, 2025

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions
06:18

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions

Published on: April 5, 2024

1.1K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.0K

科学领域:

  • 在瘤学瘤学.
  • 基因组学就是基因组学.
  • 翻译医学是一种翻译医学.

背景情况:

  • 精准癌症医学在过去二十年中取得了重大进展.
  • 未来的发展需要将复杂的分子数据整合到临床实践中.

研究的目的:

  • 审查诊断工具,临床研究和合作努力,以推进精确的癌症医学.
  • 突出可扩展的诊断和适应性分析的重要性.

主要方法:

  • 审查当前的诊断技术,包括基于组织和液体的测试.
  • 分析创新的临床试验设计和现实世界的证据的作用.
  • 审查监管和卫生技术评估协调.

主要成果:

  • 可扩展的分子诊断和适应性分析对于将复杂数据转化为可操作的临床信息至关重要.
  • 智能临床试验和现实世界的证据对于扩大治疗选择至关重要.
  • 多中心网络是实施精密瘤学和改善患者护理的关键.

结论:

  • 精准癌症医学是一个多学科的努力,需要社会参与.
  • 集成先进的诊断,适应性策略和协作研究对于未来的进步至关重要.
  • 与监管机构和国际网络的协调对于实现精密瘤学的全部潜力至关重要.